2022版《全球哮喘管理和预防策略》更新解读  

Global Strategy for Asthma Management and Prevention:Interpretation of the Updates in 2022

作　　者：常春[1] 孙永昌[1] CHANG Chun;SUN Yongchang(Department of Respiratory and Critical Care Medicine,Peking University Third Hospital,Beijing 100000,China)

机构地区：[1]北京大学第三医院呼吸与危重症医学科,北京市100000

出　　处：《中国全科医学》2022年第35期4355-4362,共8页Chinese General Practice

摘　　要：哮喘是影响所有年龄段人群健康的全球问题,1995年“全球哮喘防治创议(Global Initiative for Asthma,GINA)”专家组出版了《全球哮喘管理和预防策略》(GINA报告)。2022年世界防治哮喘日(5月3日),GINA专家组发布了2022版《全球哮喘管理和预防策略》(GINA 2022),其中纳入了有关哮喘的新科学证据。我国哮喘患病率呈逐年增长趋势,且目前我国哮喘总体控制水平尚不理想。本文主要对GINA 2022的更新要点进行解读,探讨新型冠状病毒肺炎(COVID-19)流行期间哮喘的管理问题,并提出GINA 2022对国内哮喘诊治的借鉴意义。Asthma is a serious health problem affecting people of all ages worldwide.To address asthma,the Global Initiative for Asthma Expert Group published the Global Strategy for Asthma Management and Prevention in 1995,and an updated version(GINA 2022)with new evidence being incorporated,on the World Asthma Day,May 3,2022.Asthma prevalence is increasing but is unsatisfactorily controlled generally in China.We mainly interpreted the update points in the GINA 2022,discussed the management of asthma during the COVID-19 pandemic,and assessed the significance of the GINA 2022 for the diagnosis and treatment of asthma in China.

关 键 词：哮喘 全球哮喘管理和预防战略 哮喘-慢性阻塞性肺疾病重叠综合征 疾病管理 诊断 治疗 COVID-19 

分 类 号：R562.25[医药卫生—呼吸系统]